RxDoctor Payments Data

Mark Priest, DO

Family Medicine · Traverse City, MINPI 1720157688

Payments from drug & device makers

$518in general payments, 2019–2025

Across 29 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$260
  • GSK$81
  • Johnson & Johnson$48
  • Medtronic$27
  • Lilly USA, LLC$24
  • Astellas Pharma US Inc$21
  • plus $58 from 4 others

What the payments were for

  • Food & beverage$518100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$518 in reported general payments places this provider in the 60th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$166,862
Medicare patients
517
Services billed
4,206

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EnbrelEtanercept12$85,985
EliquisApixaban78$70,730
TrulicityDulaglutide60$70,384
OzempicSemaglutide61$66,765
JardianceEmpagliflozin45$52,952
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$30,322
XareltoRivaroxaban32$26,455
FarxigaDapagliflozin Propanediol11$16,932
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr29$14,584
MyrbetriqMirabegron17$14,439
LinzessLinaclotide23$14,397
InvokanaCanagliflozin13$13,826
Tresiba Flextouch U-200Insulin Degludec18$13,443
Breo ElliptaFluticasone/Vilanterol29$11,439
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$5,961

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$24$70,38460 claims
Novo NordiskOzempic$14$66,76561 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta$81$62,049115 claims
Johnson & JohnsonXarelto, Invokana$48$40,28145 claims
Astellas Pharma US IncMyrbetriq$21$14,43917 claims
AbbVieLinzess$260$14,39723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Traverse City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →